SPX3,825.33+39.95 1.06%
DIA310.85+3.03 0.98%
IXIC11,127.85+99.11 0.90%

InMed Launches THCV, Expanding Its Portfolio Of Rare Cannabinoids

Produces highly pure d9-dominant THCV, a non-intoxicating cannabinoid Bolsters Company’s commercial portfolio, which also includes CBDV, CBC and CBT THCV has been researched for a variety of potential

Benzinga · 06/09/2022 07:34
  • Produces highly pure d9-dominant THCV, a non-intoxicating cannabinoid

  • Bolsters Company’s commercial portfolio, which also includes CBDV, CBC and CBT
  • THCV has been researched for a variety of potential benefits